<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1987-08-13" modified="2020-08-12" version="218">
<accession>P05093</accession>
<accession>Q5TZV7</accession>
<name>CP17A_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="29">Steroid 17-alpha-hydroxylase/17,20 lyase</fullName>
<ecNumber evidence="13 16 18">1.14.14.19</ecNumber>
</recommendedName>
<alternativeName>
<fullName>17-alpha-hydroxyprogesterone aldolase</fullName>
<ecNumber evidence="13 16 18">1.14.14.32</ecNumber>
</alternativeName>
<alternativeName>
<fullName>CYPXVII</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="28">Cytochrome P450 17A1</fullName>
</alternativeName>
<alternativeName>
<fullName>Cytochrome P450-C17</fullName>
<shortName evidence="30">Cytochrome P450c17</shortName>
</alternativeName>
<alternativeName>
<fullName>Steroid 17-alpha-monooxygenase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="27 37">CYP17A1</name>
<name type="synonym">CYP17</name>
<name type="synonym">S17AH</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1987" name="Proc. Natl. Acad. Sci. U.S.A." volume="84" first="407" last="411">
<title>Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues.</title>
<authorList>
<person name="Chung B.-C."/>
<person name="Picado-Leonard J."/>
<person name="Haniu M."/>
<person name="Bienkowski M."/>
<person name="Hall P.F."/>
<person name="Shively J.E."/>
<person name="Miller W.L."/>
</authorList>
<dbReference type="PubMed" id="3025870"/>
<dbReference type="DOI" id="10.1073/pnas.84.2.407"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1987" name="DNA" volume="6" first="439" last="448">
<title>Cloning and sequence of the human gene for P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): similarity with the gene for P450c21.</title>
<authorList>
<person name="Picado-Leonard J."/>
<person name="Miller W.L."/>
</authorList>
<dbReference type="PubMed" id="3500022"/>
<dbReference type="DOI" id="10.1089/dna.1987.6.439"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1987" name="Mol. Endocrinol." volume="1" first="348" last="354">
<title>Characterization of complementary deoxyribonucleic acid for human adrenocortical 17 alpha-hydroxylase: a probe for analysis of 17 alpha-hydroxylase deficiency.</title>
<authorList>
<person name="Bradshaw K.D."/>
<person name="Waterman M.R."/>
<person name="Couch R.T."/>
<person name="Simpson E.R."/>
<person name="Zuber M.X."/>
</authorList>
<dbReference type="PubMed" id="3274893"/>
<dbReference type="DOI" id="10.1210/mend-1-5-348"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1990" name="Mol. Endocrinol." volume="4" first="1972" last="1979">
<title>Tissue-specific, cyclic adenosine 3',5'-monophosphate-induced, and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells.</title>
<authorList>
<person name="Brentano S.T."/>
<person name="Picado-Leonard J."/>
<person name="Mellon S.H."/>
<person name="Moore C.C."/>
<person name="Miller W.L."/>
</authorList>
<dbReference type="PubMed" id="1964490"/>
<dbReference type="DOI" id="10.1210/mend-4-12-1972"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1988" name="Mol. Endocrinol." volume="2" first="564" last="570">
<title>Structural characterization of normal and mutant human steroid 17 alpha-hydroxylase genes: molecular basis of one example of combined 17 alpha-hydroxylase/17,20 lyase deficiency.</title>
<authorList>
<person name="Kagimoto M."/>
<person name="Winter J.S.D."/>
<person name="Kagimoto K."/>
<person name="Simpson E.R."/>
<person name="Waterman M.R."/>
</authorList>
<dbReference type="PubMed" id="2843762"/>
<dbReference type="DOI" id="10.1210/mend-2-6-564"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2004-10" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
<title>The DNA sequence and comparative analysis of human chromosome 10.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Earthrowl M.E."/>
<person name="Grafham D.V."/>
<person name="Rubenfield M."/>
<person name="French L."/>
<person name="Steward C.A."/>
<person name="Sims S.K."/>
<person name="Jones M.C."/>
<person name="Searle S."/>
<person name="Scott C."/>
<person name="Howe K."/>
<person name="Hunt S.E."/>
<person name="Andrews T.D."/>
<person name="Gilbert J.G.R."/>
<person name="Swarbreck D."/>
<person name="Ashurst J.L."/>
<person name="Taylor A."/>
<person name="Battles J."/>
<person name="Bird C.P."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ashwell R.I.S."/>
<person name="Ambrose K.D."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Cahill P."/>
<person name="Camire D."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Corby N."/>
<person name="Coulson A."/>
<person name="Dhami P."/>
<person name="Dutta I."/>
<person name="Dunn M."/>
<person name="Faulkner L."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gustafson E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E."/>
<person name="Heath P.D."/>
<person name="Ho T.P."/>
<person name="Hopkins B."/>
<person name="Horne J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hynds C."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kana A."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="Kershaw J.K."/>
<person name="Kokkinaki M."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lee H.M."/>
<person name="Leongamornlert D.A."/>
<person name="Laird G."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nguyen M."/>
<person name="Overton-Larty E."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K."/>
<person name="Rice C.M."/>
<person name="Rogosin A."/>
<person name="Ross M.T."/>
<person name="Sarafidou T."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Standring L."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Torcasso W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tsolas J."/>
<person name="Wall M."/>
<person name="Walsh J."/>
<person name="Wang H."/>
<person name="Weinstock K."/>
<person name="West A.P."/>
<person name="Willey D.L."/>
<person name="Whitehead S.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Chen Y."/>
<person name="Lovering R.C."/>
<person name="Moschonas N.K."/>
<person name="Siebert R."/>
<person name="Fechtel K."/>
<person name="Bentley D."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Doucette-Stamm L."/>
<person name="Beck S."/>
<person name="Smith D.R."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="15164054"/>
<dbReference type="DOI" id="10.1038/nature02462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="3158" last="3165">
<title>Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer.</title>
<authorList>
<person name="Auchus R.J."/>
<person name="Lee T.C."/>
<person name="Miller W.L."/>
</authorList>
<dbReference type="PubMed" id="9452426"/>
<dbReference type="DOI" id="10.1074/jbc.273.6.3158"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>PATHWAY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2016" name="J. Biol. Chem." volume="291" first="17143" last="17164">
<title>Mechanism of 17alpha,20-Lyase and New Hydroxylation Reactions of Human Cytochrome P450 17A1: 18O LABELING AND OXYGEN SURROGATE EVIDENCE FOR A ROLE OF A PERFERRYL OXYGEN.</title>
<authorList>
<person name="Yoshimoto F.K."/>
<person name="Gonzalez E."/>
<person name="Auchus R.J."/>
<person name="Guengerich F.P."/>
</authorList>
<dbReference type="PubMed" id="27339894"/>
<dbReference type="DOI" id="10.1074/jbc.m116.732966"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>PATHWAY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Mol. Endocrinol." volume="13" first="1169" last="1182">
<title>Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations.</title>
<authorList>
<person name="Auchus R.J."/>
<person name="Miller W.L."/>
</authorList>
<dbReference type="PubMed" id="10406467"/>
<dbReference type="DOI" id="10.1210/mend.13.7.0326"/>
</citation>
<scope>3D-STRUCTURE MODELING OF 48-501</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2012" name="Nature" volume="482" first="116" last="119">
<title>Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001.</title>
<authorList>
<person name="DeVore N.M."/>
<person name="Scott E.E."/>
</authorList>
<dbReference type="PubMed" id="22266943"/>
<dbReference type="DOI" id="10.1038/nature10743"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 24-508 IN COMPLEXES WITH HEME; ABIRATERONE AND TOK-001</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>COFACTOR</scope>
<scope>PATHWAY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="32952" last="32964">
<title>Structures of human steroidogenic cytochrome P450 17A1 with substrates.</title>
<authorList>
<person name="Petrunak E.M."/>
<person name="DeVore N.M."/>
<person name="Porubsky P.R."/>
<person name="Scott E.E."/>
</authorList>
<dbReference type="PubMed" id="25301938"/>
<dbReference type="DOI" id="10.1074/jbc.m114.610998"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 24-508 IN COMPLEX WITH HEME AND PREGNENOLONE</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>COFACTOR</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>PATHWAY</scope>
<scope>MUTAGENESIS OF ALA-105</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1989" name="J. Biol. Chem." volume="264" first="18076" last="18082">
<title>Deletion of a phenylalanine in the N-terminal region of human cytochrome P-450(17 alpha) results in partial combined 17 alpha-hydroxylase/17,20-lyase deficiency.</title>
<authorList>
<person name="Yanase T."/>
<person name="Kagimoto M."/>
<person name="Suzuki S."/>
<person name="Hashiba K."/>
<person name="Simpson E.R."/>
<person name="Waterman M.R."/>
</authorList>
<dbReference type="PubMed" id="2808364"/>
</citation>
<scope>VARIANT AH5 PHE-53 DEL</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="15992" last="15998">
<title>Missense mutation serine106--&gt;proline causes 17 alpha-hydroxylase deficiency.</title>
<authorList>
<person name="Lin D."/>
<person name="Harikrishna J.A."/>
<person name="Moore C.C.D."/>
<person name="Jones K.L."/>
<person name="Miller W.L."/>
</authorList>
<dbReference type="PubMed" id="1714904"/>
</citation>
<scope>VARIANT AH5 PRO-106</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1992" name="Biochim. Biophys. Acta" volume="1139" first="275" last="279">
<title>Molecular basis of apparent isolated 17,20-lyase deficiency: compound heterozygous mutations in the C-terminal region (Arg(496)--&gt;Cys, Gln(461)--&gt;Stop) actually cause combined 17 alpha-hydroxylase/17,20-lyase deficiency.</title>
<authorList>
<person name="Yanase T."/>
<person name="Waterman M.R."/>
<person name="Zachmann M."/>
<person name="Winter J.S.D."/>
<person name="Kagimoto M."/>
</authorList>
<dbReference type="PubMed" id="1515452"/>
<dbReference type="DOI" id="10.1016/0925-4439(92)90100-2"/>
</citation>
<scope>VARIANT AH5 CYS-496</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1992" name="J. Clin. Endocrinol. Metab." volume="74" first="667" last="672">
<title>Compound heterozygous mutations (Arg 239--&gt;Stop, Pro 342--&gt;Thr) in the CYP17 (P45017 alpha) gene lead to ambiguous external genitalia in a male patient with partial combined 17 alpha-hydroxylase/17,20-lyase deficiency.</title>
<authorList>
<person name="Ahlgren R."/>
<person name="Yanase T."/>
<person name="Simpson E.R."/>
<person name="Winter J.S.D."/>
<person name="Waterman M.R."/>
</authorList>
<dbReference type="PubMed" id="1740503"/>
<dbReference type="DOI" id="10.1210/jcem.74.3.1740503"/>
</citation>
<scope>VARIANT AH5 THR-342</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="19681" last="19689">
<title>Expression and purification of functional human 17 alpha-hydroxylase/17,20-lyase (P450c17) in Escherichia coli. Use of this system for study of a novel form of combined 17 alpha-hydroxylase/17,20-lyase deficiency.</title>
<authorList>
<person name="Imai T."/>
<person name="Globerman H."/>
<person name="Gertner J.M."/>
<person name="Kagawa N."/>
<person name="Waterman M.R."/>
</authorList>
<dbReference type="PubMed" id="8396144"/>
</citation>
<scope>VARIANTS AH5 SER-64 AND ILE-112 INS</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="25811" last="25817">
<title>Mutation of histidine 373 to leucine in cytochrome P450c17 causes 17 alpha-hydroxylase deficiency.</title>
<authorList>
<person name="Monno S."/>
<person name="Ogawa H."/>
<person name="Date T."/>
<person name="Fujioka M."/>
<person name="Miller W.L."/>
<person name="Kobayashi M."/>
</authorList>
<dbReference type="PubMed" id="8245018"/>
</citation>
<scope>VARIANT AH5 LEU-373</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1993" name="J. Clin. Endocrinol. Metab." volume="77" first="489" last="493">
<title>Deletion of amino acids Asp487-Ser488-Phe489 in human cytochrome P450c17 causes severe 17 alpha-hydroxylase deficiency.</title>
<authorList>
<person name="Fardella C.E."/>
<person name="Zhang L.H."/>
<person name="Mahacholklertwattana P."/>
<person name="Lin D."/>
<person name="Miller W.L."/>
</authorList>
<dbReference type="PubMed" id="8345056"/>
<dbReference type="DOI" id="10.1210/jcem.77.2.8345056"/>
</citation>
<scope>VARIANT AH5 487-ASP--PHE-489 DEL</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1994" name="J. Clin. Endocrinol. Metab." volume="79" first="160" last="164">
<title>Point mutation of Arg440 to His in cytochrome P450c17 causes severe 17 alpha-hydroxylase deficiency.</title>
<authorList>
<person name="Fardella C.E."/>
<person name="Hum D.W."/>
<person name="Homoki J."/>
<person name="Miller W.L."/>
</authorList>
<dbReference type="PubMed" id="8027220"/>
<dbReference type="DOI" id="10.1210/jcem.79.1.8027220"/>
</citation>
<scope>VARIANT AH5 HIS-440</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1996" name="J. Clin. Endocrinol. Metab." volume="81" first="264" last="268">
<title>Mutation R96W in cytochrome P450c17 gene causes combined 17 alpha-hydroxylase/17-20-lyase deficiency in two French Canadian patients.</title>
<authorList>
<person name="Laflamme N."/>
<person name="Leblanc J.-F."/>
<person name="Mailloux J."/>
<person name="Faure N."/>
<person name="Labrie F."/>
<person name="Simard J."/>
</authorList>
<dbReference type="PubMed" id="8550762"/>
<dbReference type="DOI" id="10.1210/jcem.81.1.8550762"/>
</citation>
<scope>VARIANT AH5 TRP-96</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1996" name="Pediatr. Res." volume="39" first="89A" last="89A">
<title>The molecular basis of isolated 17,20 lyase deficiency.</title>
<authorList>
<person name="Geller D.H."/>
<person name="Mendonca B.B."/>
<person name="Miller W.L."/>
</authorList>
</citation>
<scope>VARIANTS AH5 HIS-347 AND GLN-358</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2000" name="J. Clin. Endocrinol. Metab." volume="85" first="1226" last="1231">
<title>17alpha-hydroxylase/17,20-lyase deficiency as a model to study enzymatic activity regulation: role of phosphorylation.</title>
<authorList>
<person name="Biason-Lauber A."/>
<person name="Kempken B."/>
<person name="Werder E."/>
<person name="Forest M.G."/>
<person name="Einaudi S."/>
<person name="Ranke M.B."/>
<person name="Matsuo N."/>
<person name="Brunelli V."/>
<person name="Schoenle E.J."/>
<person name="Zachmann M."/>
</authorList>
<dbReference type="PubMed" id="10720067"/>
<dbReference type="DOI" id="10.1210/jcem.85.3.6475"/>
</citation>
<scope>VARIANTS AH5 LEU-35; PHE-53 DEL; TRP-96; ASP-177; GLU-330 DEL; CYS-417 AND HIS-496</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2001" name="J. Clin. Endocrinol. Metab." volume="86" first="4416" last="4423">
<title>Pitfalls in characterizing P450c17 mutations associated with isolated 17,20-lyase deficiency.</title>
<authorList>
<person name="Gupta M.K."/>
<person name="Geller D.H."/>
<person name="Auchus R.J."/>
</authorList>
<dbReference type="PubMed" id="11549685"/>
<dbReference type="DOI" id="10.1210/jcem.86.9.7812"/>
</citation>
<scope>VARIANTS AH5 HIS-347; GLN-358 AND CYS-417</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2002" name="J. Clin. Endocrinol. Metab." volume="87" first="898" last="905">
<title>Combined 17alpha-hydroxylase/17,20-lyase deficiency caused by Phe93Cys mutation in the CYP17 gene.</title>
<authorList>
<person name="Di Cerbo A."/>
<person name="Biason-Lauber A."/>
<person name="Savino M."/>
<person name="Piemontese M.R."/>
<person name="Di Giorgio A."/>
<person name="Perona M."/>
<person name="Savoia A."/>
</authorList>
<dbReference type="PubMed" id="11836339"/>
<dbReference type="DOI" id="10.1210/jcem.87.2.8271"/>
</citation>
<scope>VARIANT AH5 CYS-93</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2002" name="J. Clin. Endocrinol. Metab." volume="87" first="5714" last="5721">
<title>Differential inhibition of 17alpha-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency.</title>
<authorList>
<person name="Van Den Akker E.L.T."/>
<person name="Koper J.W."/>
<person name="Boehmer A.L.M."/>
<person name="Themmen A.P.N."/>
<person name="Verhoef-Post M."/>
<person name="Timmerman M.A."/>
<person name="Otten B.J."/>
<person name="Drop S.L.S."/>
<person name="De Jong F.H."/>
</authorList>
<dbReference type="PubMed" id="12466376"/>
<dbReference type="DOI" id="10.1210/jc.2001-011880"/>
</citation>
<scope>VARIANTS AH5 VAL-114; VAL-116; CYS-347 AND HIS-347</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2003" name="J. Clin. Endocrinol. Metab." volume="88" first="5739" last="5746">
<title>P450c17 deficiency in Brazilian patients: biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping.</title>
<authorList>
<person name="Martin R.M."/>
<person name="Lin C.J."/>
<person name="Costa E.M.F."/>
<person name="de Oliveira M.L."/>
<person name="Carrilho A."/>
<person name="Villar H."/>
<person name="Longui C.A."/>
<person name="Mendonca B.B."/>
</authorList>
<dbReference type="PubMed" id="14671162"/>
<dbReference type="DOI" id="10.1210/jc.2003-030988"/>
</citation>
<scope>VARIANTS AH5 TRP-96; ASP-329; CYS-362; ARG-406 AND LEU-428</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Metabolism" volume="59" first="275" last="278">
<title>Novel CYP17A1 mutation in a Japanese patient with combined 17alpha-hydroxylase/17,20-lyase deficiency.</title>
<authorList>
<person name="Katsumata N."/>
<person name="Ogawa E."/>
<person name="Fujiwara I."/>
<person name="Fujikura K."/>
</authorList>
<dbReference type="PubMed" id="19793597"/>
<dbReference type="DOI" id="10.1016/j.metabol.2009.07.024"/>
</citation>
<scope>VARIANTS AH5 PHE-53 DEL AND ASN-373</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2014" name="Oman Med. J." volume="29" first="55" last="59">
<title>Congenital adrenal hyperplasia due to 17-alpha-hydoxylase/17,20-lyase deficiency presenting with hypertension and pseudohermaphroditism: first case report from Oman.</title>
<authorList>
<person name="Mula-Abed W.A."/>
<person name="Pambinezhuth F.B."/>
<person name="Al-Kindi M.K."/>
<person name="Al-Busaidi N.B."/>
<person name="Al-Muslahi H.N."/>
<person name="Al-Lamki M.A."/>
</authorList>
<dbReference type="PubMed" id="24498484"/>
<dbReference type="DOI" id="10.5001/omj.2014.12"/>
</citation>
<scope>VARIANT AH5 GLN-96</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2014" name="Metabolism" volume="63" first="42" last="49">
<title>A review of the literature on common CYP17A1 mutations in adults with 17-hydroxylase/17,20-lyase deficiency, a case series of such mutations among Koreans and functional characteristics of a novel mutation.</title>
<authorList>
<person name="Kim Y.M."/>
<person name="Kang M."/>
<person name="Choi J.H."/>
<person name="Lee B.H."/>
<person name="Kim G.H."/>
<person name="Ohn J.H."/>
<person name="Kim S.Y."/>
<person name="Park M.S."/>
<person name="Yoo H.W."/>
</authorList>
<dbReference type="PubMed" id="24140098"/>
<dbReference type="DOI" id="10.1016/j.metabol.2013.08.015"/>
</citation>
<scope>VARIANTS AH5 GLU-174; LEU-373 AND LEU-406</scope>
<scope>CHARACTERIZATION OF VARIANT AH5 LEU-406</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2015" name="Eur. J. Endocrinol." volume="172" first="K19" last="25">
<title>Partial deficiency of 17alpha-hydroxylase/17,20-lyase caused by a novel missense mutation in the canonical cytochrome heme-interacting motif.</title>
<authorList>
<person name="Rubtsov P."/>
<person name="Nizhnik A."/>
<person name="Dedov I.I."/>
<person name="Kalinchenko N."/>
<person name="Petrov V."/>
<person name="Orekhova A."/>
<person name="Spirin P."/>
<person name="Prassolov V."/>
<person name="Tiulpakov A."/>
</authorList>
<dbReference type="PubMed" id="25650406"/>
<dbReference type="DOI" id="10.1530/eje-14-0834"/>
</citation>
<scope>VARIANT AH5 ARG-121</scope>
<scope>CHARACTERIZATION OF VARIANT AH5 ARG-121</scope>
</reference>
<comment type="function">
<text evidence="13 16 18 25 35">A cytochrome P450 monooxygenase involved in corticoid and androgen biosynthesis (PubMed:9452426, PubMed:27339894, PubMed:22266943, PubMed:25301938). Catalyzes 17-alpha hydroxylation of C21 steroids, which is common for both pathways. A second oxidative step, required only for androgen synthesis, involves an acyl-carbon cleavage. The 17-alpha hydroxy intermediates, as part of adrenal glucocorticoids biosynthesis pathway, are precursors of cortisol (PubMed:9452426, PubMed:25301938) (Probable). Hydroxylates steroid hormones, pregnenolone and progesterone to form 17-alpha hydroxy metabolites, followed by the cleavage of the C17-C20 bond to form C19 steroids, dehydroepiandrosterone (DHEA) and androstenedione (PubMed:9452426, PubMed:27339894, PubMed:22266943, PubMed:25301938). Has 16-alpha hydroxylase activity. Catalyzes 16-alpha hydroxylation of 17-alpha hydroxy pregnenolone, followed by the cleavage of the C17-C20 bond to form 16-alpha-hydroxy DHEA. Also 16-alpha hydroxylates androgens, relevant for estriol synthesis (PubMed:27339894, PubMed:25301938). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) (PubMed:9452426, PubMed:27339894, PubMed:22266943, PubMed:25301938).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="13 16 18">
<text>A C(21)-steroid + [reduced NADPH--hemoprotein reductase] + O(2) = a 17-alpha-hydroxy-C(21)-steroid + [oxidized NADPH--hemoprotein reductase] + H(2)O.</text>
<dbReference type="EC" id="1.14.14.19"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="16 25">
<text>O2 + progesterone + reduced [NADPH--hemoprotein reductase] = 17alpha-hydroxyprogesterone + H(+) + H2O + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:46308"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17026"/>
<dbReference type="ChEBI" id="CHEBI:17252"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="36">
<dbReference type="Rhea" id="RHEA:46309"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="13 18">
<text>17alpha-hydroxyprogesterone + O2 + reduced [NADPH--hemoprotein reductase] = acetate + androst-4-ene-3,17-dione + 2 H(+) + H2O + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:14753"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:16422"/>
<dbReference type="ChEBI" id="CHEBI:17252"/>
<dbReference type="ChEBI" id="CHEBI:30089"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
<dbReference type="EC" id="1.14.14.32"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="32">
<dbReference type="Rhea" id="RHEA:14754"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="18">
<text>17alpha-hydroxyprogesterone + O2 + reduced [NADPH--hemoprotein reductase] = 16alpha,17alpha-dihydroxyprogesterone + H(+) + H2O + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:53216"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:763"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17252"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="33">
<dbReference type="Rhea" id="RHEA:53217"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="18">
<text>16alpha,17alpha-dihydroxyprogesterone + O2 + reduced [NADPH--hemoprotein reductase] = 6beta,16alpha,17alpha-trihydroxyprogesterone + H(+) + H2O + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:53220"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:763"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
<dbReference type="ChEBI" id="CHEBI:137046"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="33">
<dbReference type="Rhea" id="RHEA:53221"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="25">
<text>O2 + pregnenolone + reduced [NADPH--hemoprotein reductase] = 17alpha-hydroxypregnenolone + H(+) + H2O + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:50236"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:16581"/>
<dbReference type="ChEBI" id="CHEBI:28750"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="36">
<dbReference type="Rhea" id="RHEA:50237"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="13 16 18">
<text>17alpha-hydroxypregnenolone + O2 + reduced [NADPH--hemoprotein reductase] = 3beta-hydroxyandrost-5-en-17-one + acetate + 2 H(+) + H2O + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:50244"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:28689"/>
<dbReference type="ChEBI" id="CHEBI:28750"/>
<dbReference type="ChEBI" id="CHEBI:30089"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
<dbReference type="EC" id="1.14.14.32"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="32">
<dbReference type="Rhea" id="RHEA:50245"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="16 18">
<text>16alpha,17alpha-dihydroxypregnenolone + O2 + reduced [NADPH--hemoprotein reductase] = 3beta,16alpha-dihydroxy-androst-5-en-17-one + acetate + 2 H(+) + H2O + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:53224"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:27771"/>
<dbReference type="ChEBI" id="CHEBI:30089"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
<dbReference type="ChEBI" id="CHEBI:137049"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="33">
<dbReference type="Rhea" id="RHEA:53225"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="18">
<text>3beta-hydroxyandrost-5-en-17-one + O2 + reduced [NADPH--hemoprotein reductase] = 3beta,16alpha-dihydroxy-androst-5-en-17-one + H(+) + H2O + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:47220"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:27771"/>
<dbReference type="ChEBI" id="CHEBI:28689"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="33">
<dbReference type="Rhea" id="RHEA:47221"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="18">
<text>androst-4-ene-3,17-dione + O2 + reduced [NADPH--hemoprotein reductase] = 16alpha-hydroxyandrost-4-ene-3,17-dione + H(+) + H2O + oxidized [NADPH--hemoprotein reductase]</text>
<dbReference type="Rhea" id="RHEA:53228"/>
<dbReference type="Rhea" id="RHEA-COMP:11964"/>
<dbReference type="Rhea" id="RHEA-COMP:11965"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:16422"/>
<dbReference type="ChEBI" id="CHEBI:27582"/>
<dbReference type="ChEBI" id="CHEBI:57618"/>
<dbReference type="ChEBI" id="CHEBI:58210"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="33">
<dbReference type="Rhea" id="RHEA:53229"/>
</physiologicalReaction>
</comment>
<comment type="cofactor">
<cofactor evidence="13 16">
<name>heme</name>
<dbReference type="ChEBI" id="CHEBI:30413"/>
</cofactor>
</comment>
<comment type="activity regulation">
<text evidence="4 18 25">Regulated predominantly by intracellular cAMP levels (PubMed:10720067). The 17,20-lyase activity is stimulated by cytochrome b5, which acts as an allosteric effector increasing the Vmax of the lyase activity (PubMed:9452426, PubMed:27339894).</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="16">10.5 uM for progesterone (17-alpha hydroxylation)</KM>
<KM evidence="16">0.93 uM for pregnenolone (17-alpha hydroxylation)</KM>
<KM evidence="16">1.2 uM for 17alpha-hydroxypregnenolone (17,20 lyase activity)</KM>
<text>kcat is 1.01 min(-1) with progesterone as substrate. kcat is 0.39 min(-1) with pregnenolone as substrate. kcat is 0.24 min(-1) with 17alpha-hydroxypregnenolone as substrate.</text>
</kinetics>
</comment>
<comment type="pathway" evidence="13 16 18 25">
<text>Steroid hormone biosynthesis.</text>
</comment>
<comment type="pathway" evidence="16 25">
<text>Steroid biosynthesis; glucocorticoid biosynthesis.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="34">Endoplasmic reticulum membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="34">Microsome membrane</location>
</subcellularLocation>
</comment>
<comment type="PTM">
<text evidence="4">Phosphorylation is necessary for 17,20-lyase, but not for 17-alpha-hydroxylase activity.</text>
</comment>
<comment type="disease" evidence="4 5 6 7 8 9 10 11 12 14 15 17 19 20 21 22 23 24 26">
<disease id="DI-00045">
<name>Adrenal hyperplasia 5</name>
<acronym>AH5</acronym>
<description>A form of congenital adrenal hyperplasia, a common recessive disease due to defective synthesis of cortisol. Congenital adrenal hyperplasia is characterized by androgen excess leading to ambiguous genitalia in affected females, rapid somatic growth during childhood in both sexes with premature closure of the epiphyses and short adult stature. Four clinical types: 'salt wasting' (SW, the most severe type), 'simple virilizing' (SV, less severely affected patients), with normal aldosterone biosynthesis, 'non-classic form' or late-onset (NC or LOAH) and 'cryptic' (asymptomatic).</description>
<dbReference type="MIM" id="202110"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="31">Belongs to the cytochrome P450 family.</text>
</comment>
<comment type="online information" name="SHMPD">
<link uri="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&amp;genename=CYP17A1"/>
<text>The Singapore human mutation and polymorphism database</text>
</comment>
<dbReference type="EC" id="1.14.14.19" evidence="13 16 18"/>
<dbReference type="EC" id="1.14.14.32" evidence="13 16 18"/>
<dbReference type="EMBL" id="M14564">
<property type="protein sequence ID" value="AAA52151.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M19489">
<property type="protein sequence ID" value="AAA36405.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M63871">
<property type="protein sequence ID" value="AAA59984.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M31153">
<property type="protein sequence ID" value="AAA52140.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M31146">
<property type="protein sequence ID" value="AAA52140.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M31147">
<property type="protein sequence ID" value="AAA52140.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M31148">
<property type="protein sequence ID" value="AAA52140.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M31149">
<property type="protein sequence ID" value="AAA52140.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M31150">
<property type="protein sequence ID" value="AAA52140.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M31151">
<property type="protein sequence ID" value="AAA52140.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M31152">
<property type="protein sequence ID" value="AAA52140.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BT020000">
<property type="protein sequence ID" value="AAV38803.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL358790">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC062997">
<property type="protein sequence ID" value="AAH62997.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC063388">
<property type="protein sequence ID" value="AAH63388.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7541.1"/>
<dbReference type="PIR" id="A40921">
<property type="entry name" value="A26366"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000093.1">
<property type="nucleotide sequence ID" value="NM_000102.3"/>
</dbReference>
<dbReference type="PDB" id="2C17">
<property type="method" value="Model"/>
<property type="chains" value="A=48-501"/>
</dbReference>
<dbReference type="PDB" id="3RUK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B/C/D=24-508"/>
</dbReference>
<dbReference type="PDB" id="3SWZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/C/D=24-508"/>
</dbReference>
<dbReference type="PDB" id="4NKV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A/B/C/D=24-508"/>
</dbReference>
<dbReference type="PDB" id="4NKW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/C/D=24-508"/>
</dbReference>
<dbReference type="PDB" id="4NKX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.79"/>
<property type="chains" value="A/B/C/D=24-508"/>
</dbReference>
<dbReference type="PDB" id="4NKY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A/B/C/D=24-508"/>
</dbReference>
<dbReference type="PDB" id="4NKZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B/C/D=24-508"/>
</dbReference>
<dbReference type="PDB" id="5IRQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/C/D=24-508"/>
</dbReference>
<dbReference type="PDB" id="5IRV">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B/C/D=24-508"/>
</dbReference>
<dbReference type="PDB" id="5UYS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.39"/>
<property type="chains" value="A/B/C/D=24-508"/>
</dbReference>
<dbReference type="PDB" id="6CHI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B/C/D=24-508"/>
</dbReference>
<dbReference type="PDB" id="6CIR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A/B/C/D=24-508"/>
</dbReference>
<dbReference type="PDB" id="6CIZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B/C/D=24-508"/>
</dbReference>
<dbReference type="PDBsum" id="2C17"/>
<dbReference type="PDBsum" id="3RUK"/>
<dbReference type="PDBsum" id="3SWZ"/>
<dbReference type="PDBsum" id="4NKV"/>
<dbReference type="PDBsum" id="4NKW"/>
<dbReference type="PDBsum" id="4NKX"/>
<dbReference type="PDBsum" id="4NKY"/>
<dbReference type="PDBsum" id="4NKZ"/>
<dbReference type="PDBsum" id="5IRQ"/>
<dbReference type="PDBsum" id="5IRV"/>
<dbReference type="PDBsum" id="5UYS"/>
<dbReference type="PDBsum" id="6CHI"/>
<dbReference type="PDBsum" id="6CIR"/>
<dbReference type="PDBsum" id="6CIZ"/>
<dbReference type="SMR" id="P05093"/>
<dbReference type="BioGRID" id="107958">
<property type="interactions" value="14"/>
</dbReference>
<dbReference type="IntAct" id="P05093">
<property type="interactions" value="13"/>
</dbReference>
<dbReference type="MINT" id="P05093"/>
<dbReference type="STRING" id="9606.ENSP00000358903"/>
<dbReference type="BindingDB" id="P05093"/>
<dbReference type="ChEMBL" id="CHEMBL3522"/>
<dbReference type="DrugBank" id="DB05812">
<property type="generic name" value="Abiraterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB04630">
<property type="generic name" value="Aldosterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01424">
<property type="generic name" value="Aminophenazone"/>
</dbReference>
<dbReference type="DrugBank" id="DB09061">
<property type="generic name" value="Cannabidiol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00882">
<property type="generic name" value="Clomifene"/>
</dbReference>
<dbReference type="DrugBank" id="DB01234">
<property type="generic name" value="Dexamethasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01026">
<property type="generic name" value="Ketoconazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB14009">
<property type="generic name" value="Medical Cannabis"/>
</dbReference>
<dbReference type="DrugBank" id="DB14011">
<property type="generic name" value="Nabiximols"/>
</dbReference>
<dbReference type="DrugBank" id="DB00157">
<property type="generic name" value="NADH"/>
</dbReference>
<dbReference type="DrugBank" id="DB01708">
<property type="generic name" value="Prasterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00396">
<property type="generic name" value="Progesterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00421">
<property type="generic name" value="Spironolactone"/>
</dbReference>
<dbReference type="DrugBank" id="DB02901">
<property type="generic name" value="Stanolone"/>
</dbReference>
<dbReference type="DrugCentral" id="P05093"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1361"/>
<dbReference type="SwissLipids" id="SLP:000001611"/>
<dbReference type="iPTMnet" id="P05093"/>
<dbReference type="PhosphoSitePlus" id="P05093"/>
<dbReference type="BioMuta" id="CYP17A1"/>
<dbReference type="DMDM" id="117283"/>
<dbReference type="MassIVE" id="P05093"/>
<dbReference type="PaxDb" id="P05093"/>
<dbReference type="PeptideAtlas" id="P05093"/>
<dbReference type="PRIDE" id="P05093"/>
<dbReference type="ProteomicsDB" id="51789"/>
<dbReference type="Antibodypedia" id="31491">
<property type="antibodies" value="597 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="1586"/>
<dbReference type="Ensembl" id="ENST00000369887">
<property type="protein sequence ID" value="ENSP00000358903"/>
<property type="gene ID" value="ENSG00000148795"/>
</dbReference>
<dbReference type="GeneID" id="1586"/>
<dbReference type="KEGG" id="hsa:1586"/>
<dbReference type="CTD" id="1586"/>
<dbReference type="DisGeNET" id="1586"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000148795.5"/>
<dbReference type="GeneCards" id="CYP17A1"/>
<dbReference type="HGNC" id="HGNC:2593">
<property type="gene designation" value="CYP17A1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000148795">
<property type="expression patterns" value="Tissue enriched (adrenal)"/>
</dbReference>
<dbReference type="MalaCards" id="CYP17A1"/>
<dbReference type="MIM" id="202110">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="609300">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P05093"/>
<dbReference type="OpenTargets" id="ENSG00000148795"/>
<dbReference type="Orphanet" id="90796">
<property type="disease" value="46,XY disorder of sex development due to isolated 17,20-lyase deficiency"/>
</dbReference>
<dbReference type="Orphanet" id="90793">
<property type="disease" value="Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27090"/>
<dbReference type="eggNOG" id="KOG0156">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155588"/>
<dbReference type="HOGENOM" id="CLU_001570_22_0_1"/>
<dbReference type="InParanoid" id="P05093"/>
<dbReference type="KO" id="K00512"/>
<dbReference type="OMA" id="ICLPRES"/>
<dbReference type="OrthoDB" id="702827at2759"/>
<dbReference type="PhylomeDB" id="P05093"/>
<dbReference type="TreeFam" id="TF105095"/>
<dbReference type="BioCyc" id="MetaCyc:HS07560-MONOMER"/>
<dbReference type="BRENDA" id="1.14.99.9">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="P05093"/>
<dbReference type="Reactome" id="R-HSA-193048">
<property type="pathway name" value="Androgen biosynthesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-194002">
<property type="pathway name" value="Glucocorticoid biosynthesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5579028">
<property type="pathway name" value="Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)"/>
</dbReference>
<dbReference type="SABIO-RK" id="P05093"/>
<dbReference type="SIGNOR" id="P05093"/>
<dbReference type="UniPathway" id="UPA00788"/>
<dbReference type="BioGRID-ORCS" id="1586">
<property type="hits" value="3 hits in 878 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CYP17A1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="CYP17A1"/>
<dbReference type="GenomeRNAi" id="1586"/>
<dbReference type="Pharos" id="P05093">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P05093"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="RNAct" id="P05093">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000148795">
<property type="expression patterns" value="Expressed in adrenal gland and 120 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P05093">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P05093">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0047442">
<property type="term" value="F:17-alpha-hydroxyprogesterone aldolase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0020037">
<property type="term" value="F:heme binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005506">
<property type="term" value="F:iron ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0019825">
<property type="term" value="F:oxygen binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004508">
<property type="term" value="F:steroid 17-alpha-monooxygenase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006702">
<property type="term" value="P:androgen biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006704">
<property type="term" value="P:glucocorticoid biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042446">
<property type="term" value="P:hormone biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042448">
<property type="term" value="P:progesterone metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007548">
<property type="term" value="P:sex differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006694">
<property type="term" value="P:steroid biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0008202">
<property type="term" value="P:steroid metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.630.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001128">
<property type="entry name" value="Cyt_P450"/>
</dbReference>
<dbReference type="InterPro" id="IPR017972">
<property type="entry name" value="Cyt_P450_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR002401">
<property type="entry name" value="Cyt_P450_E_grp-I"/>
</dbReference>
<dbReference type="InterPro" id="IPR036396">
<property type="entry name" value="Cyt_P450_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00067">
<property type="entry name" value="p450"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00463">
<property type="entry name" value="EP450I"/>
</dbReference>
<dbReference type="PRINTS" id="PR00385">
<property type="entry name" value="P450"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48264">
<property type="entry name" value="SSF48264"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00086">
<property type="entry name" value="CYTOCHROME_P450"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0954">Congenital adrenal hyperplasia</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0349">Heme</keyword>
<keyword id="KW-0408">Iron</keyword>
<keyword id="KW-0456">Lyase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0492">Microsome</keyword>
<keyword id="KW-0503">Monooxygenase</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0755">Steroidogenesis</keyword>
<feature type="chain" description="Steroid 17-alpha-hydroxylase/17,20 lyase" id="PRO_0000051931">
<location>
<begin position="1"/>
<end position="508"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron (heme axial ligand)">
<location>
<position position="442"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="16">
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs762563." id="VAR_011755">
<original>C</original>
<variation>W</variation>
<location>
<position position="22"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; 38% 17alpha-hydroxylase activity and 33% 17,20-lyase activity." id="VAR_022745" evidence="4">
<original>P</original>
<variation>L</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; 10% 17alpha-hydroxylase activity and 13% 17,20-lyase activity." id="VAR_001270" evidence="4 12 19">
<location>
<position position="53"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; dbSNP:rs1183147390." id="VAR_001271" evidence="23">
<original>Y</original>
<variation>S</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; dbSNP:rs104894146." id="VAR_013147" evidence="6">
<original>F</original>
<variation>C</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; dbSNP:rs104894153." id="VAR_073043" evidence="15">
<original>R</original>
<variation>Q</variation>
<location>
<position position="96"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; 25% of both 17alpha-hydroxylase and 17,20-lyase activities; dbSNP:rs104894138." id="VAR_022746" evidence="4 8 24">
<original>R</original>
<variation>W</variation>
<location>
<position position="96"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; dbSNP:rs104894135." id="VAR_001272" evidence="10">
<original>S</original>
<variation>P</variation>
<location>
<position position="106"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5." id="VAR_001273" evidence="23">
<original>I</original>
<variation>II</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; dbSNP:rs104894147." id="VAR_022747" evidence="7">
<original>F</original>
<variation>V</variation>
<location>
<position position="114"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; dbSNP:rs104894148." id="VAR_022748" evidence="7">
<original>D</original>
<variation>V</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; partial loss of activity." id="VAR_073044" evidence="17">
<original>W</original>
<variation>R</variation>
<location>
<position position="121"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5." id="VAR_073045" evidence="14">
<original>A</original>
<variation>E</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; 10% 17alpha-hydroxylase and 17,20-lyase activities." id="VAR_022749" evidence="4">
<original>N</original>
<variation>D</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; dbSNP:rs104894144." id="VAR_022750" evidence="8">
<original>Y</original>
<variation>D</variation>
<location>
<position position="329"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; complete loss of both 17alpha-hydroxylase and 17,20-lyase activities." id="VAR_022751" evidence="4">
<location>
<position position="330"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; dbSNP:rs104894137." id="VAR_001274" evidence="11">
<original>P</original>
<variation>T</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; dbSNP:rs104894149." id="VAR_022752" evidence="7">
<original>R</original>
<variation>C</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; selectively ablates 17,20-lyase activity, while preserving most 17alpha-hydroxylase activity; dbSNP:rs61754278." id="VAR_001275" evidence="5 7 26">
<original>R</original>
<variation>H</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; selectively ablates 17,20-lyase activity, while preserving most 17alpha-hydroxylase activity; dbSNP:rs104894139." id="VAR_001276" evidence="5 26">
<original>R</original>
<variation>Q</variation>
<location>
<position position="358"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; dbSNP:rs104894142." id="VAR_022753" evidence="8">
<original>R</original>
<variation>C</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; dbSNP:rs760695410." id="VAR_001277" evidence="14 21">
<original>H</original>
<variation>L</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; dbSNP:rs1423560123." id="VAR_073046" evidence="12">
<original>H</original>
<variation>N</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; complete loss of both 17alpha-hydroxylase and 17,20-lyase activities." id="VAR_073047" evidence="14">
<original>W</original>
<variation>L</variation>
<location>
<position position="406"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; dbSNP:rs104894143." id="VAR_022754" evidence="8">
<original>W</original>
<variation>R</variation>
<location>
<position position="406"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; ablates both 17,20-lyase activity and 17alpha-hydroxylase activity; loss of heme-binding and loss of phosphorylation; dbSNP:rs104894140." id="VAR_022755" evidence="4 5">
<original>F</original>
<variation>C</variation>
<location>
<position position="417"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; dbSNP:rs104894145." id="VAR_022756" evidence="8">
<original>P</original>
<variation>L</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; dbSNP:rs777638364." id="VAR_001278" evidence="20">
<original>R</original>
<variation>H</variation>
<location>
<position position="440"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5." id="VAR_001279" evidence="22">
<location>
<begin position="487"/>
<end position="489"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; dbSNP:rs1250463562." id="VAR_001280" evidence="9">
<original>R</original>
<variation>C</variation>
<location>
<position position="496"/>
</location>
</feature>
<feature type="sequence variant" description="In AH5; 30% 17alpha-hydroxylase activity and 29% 17,20-lyase activity; dbSNP:rs763398879." id="VAR_022757" evidence="4">
<original>R</original>
<variation>H</variation>
<location>
<position position="496"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases the affinity for progesterone, resulting in preferential hydroxylation of progesterone at C17 over C16; increases the catalytic efficiency in the 17,20 lyase reaction." evidence="16">
<original>A</original>
<variation>L</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="36"/>
<end position="42"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="49"/>
<end position="60"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="62"/>
<end position="68"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="71"/>
<end position="76"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="79"/>
<end position="86"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="87"/>
<end position="89"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="90"/>
<end position="93"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="100"/>
<end position="105"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="106"/>
<end position="109"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="111"/>
<end position="114"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="119"/>
<end position="131"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="132"/>
<end position="135"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="136"/>
<end position="138"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="142"/>
<end position="158"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="159"/>
<end position="162"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="163"/>
<end position="165"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="168"/>
<end position="184"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="193"/>
<end position="209"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="211"/>
<end position="214"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="220"/>
<end position="223"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="228"/>
<end position="251"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="262"/>
<end position="271"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="282"/>
<end position="284"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="285"/>
<end position="287"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="289"/>
<end position="320"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="322"/>
<end position="335"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="336"/>
<end position="338"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="344"/>
<end position="348"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="351"/>
<end position="363"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="376"/>
<end position="381"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="384"/>
<end position="386"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="391"/>
<end position="394"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="396"/>
<end position="401"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="403"/>
<end position="405"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="406"/>
<end position="408"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="414"/>
<end position="417"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="422"/>
<end position="425"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="438"/>
<end position="440"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="445"/>
<end position="462"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="463"/>
<end position="466"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="469"/>
<end position="471"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="479"/>
<end position="485"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="491"/>
<end position="495"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="497"/>
<end position="501"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IRQ"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UYS"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6CIR"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10720067"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11549685"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11836339"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12466376"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14671162"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1515452"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1714904"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1740503"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19793597"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22266943"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24140098"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24498484"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25301938"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25650406"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27339894"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2808364"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8027220"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8245018"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8345056"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8396144"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8550762"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9452426"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source ref="23"/>
</evidence>
<evidence key="27" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="19793597"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="27339894"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3025870"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8396144"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000305"/>
<evidence key="32" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22266943"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="27339894"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="2808364"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="8027220"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="9452426"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:2593"/>
</source>
</evidence>
<sequence length="508" mass="57371" checksum="E5454E9E18F96B0E" modified="1987-08-13" version="1">MWELVALLLLTLAYLFWPKRRCPGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGST</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

